Critical Critical Critical

Critical week amid US technology earnings and Chinese weakness

Equities 8 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Summary:  This week is all about whether global equities are about to test the lows from March or earnings are strong enough to ignite a new rebound in equities. Around 50% of the S&P 500 market capitalisation is reporting this week and major US technology companies are dominating the earnings calendar. If US technology companies can show minimal impact from inflation then equities can rebound but if not and the situation in China worsens then equities will likely remain weak.


A jolt of energy and nervousness from China

Friday’s selloff in S&P 500 futures was brutal taking the US equities down by 2.8% taking the US equity market back to levels not seen since 16 March. The selloff was unusually for the period led by commodities which were linked to increasing worries over demand from China as its zero-Covid policy is risking more lockdowns and negative impact on economic activity. These worries escalated in the Chinese session today sending the CSI 300 cash index down by 5% confirming our defensive stance we have had on Chinese equities since the Chinese technology breakdown started over a year ago. In a research note from late March we concluded that Chinese equities were not cheap despite the selloff and the lockdowns are a big tail-risk for foreign investors that are already contemplating how big the portfolio weight should be on Chinese equities going forward given the war in Ukraine. One thing is for sure, this month is becoming worse and worse for equities with only the defense theme basket being positive for the month.

China’s weakness is expressed in policy statements, but also policy actions with the latest being that Chinese banks are allowed to ease financing conditions for distressed real estate developers. In the currency market my colleagues Redmond Wong and John Hardy have recently expressed great points here and here of what is happening in China and how it relates to the currency and other markets. The market is currently saying that China’s issues is net negative for inflation in the short-term as it cools down demand for commodities, but the lockdowns also create bottlenecks and global supply constraints which are short-term inflationary, but of course not to the same degree as commodity prices themselves. However, the longer China waits in abolishing its zero-Covid policy the more the economy will need a big stimulus to recover. With the US and Europe slowing down and removing stimulus, China’s tailwind from exports will ease and a revival of the economy will have to come from domestic stimulus which could increase demand again.

With weak sentiment equities this week’s earnings releases are going to be critical for whether the market will test the March lows or it can muster a rebound. Around half of the S&P 500 market capitalization is reporting this week with US technology companies such as Alphabet, Microsoft, Meta, Apple, and Amazon dominating. As we wrote last Friday, profit margins among US large cap technology companies (Nasdaq 100) seem to be holding up despite inflation while the rest of the corporate sector is feeling the pain from rising input costs. If US technology companies as a whole this week can show that it is insulated from inflation then investors could suddenly begin treating large cap technology stocks as an inflation hedge and prop up the broader equity market while the long tail of non-technology companies will continue to suffer from inflation.

Today’s earnings from Coca-Cola and Activision Blizzard show that consumer companies such as P&G and Coca-Cola have for now the ability to pass on the rising costs. Netflix earnings showed that entertainment stocks that benefitted during the pandemic are paying back some of those gains as consumers are spending their time differently. Activision Blizzard has posted Q1 revenue of $1.48bn vs est. $1.81bn expected and adj. EPS is $0.38 vs est. $0.72 hinting potentially at more disappointments on technology earnings this week, but only time will tell.

We are also waiting for the latest update on Chicago Fed’s financial conditions index as a further push towards average financial conditions will weaken equities. The battle for Donbas in Ukraine has not yet been the source of risk investors feared but the pressure on the Russian military to deliver results by 9 May is increasing and the war in Ukraine is still a major latent tail-risk ready to show its ugly face at any time.

Source: Saxo Group
Source: Bloomberg
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.